Evidence map›Paper›PMID 19099580›Full record

ArticleGenome biology2008

A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.

Alyson Ashe, Daniel K Morgan, Nadia C Whitelaw, Timothy J Bruxner, Nicola K Vickaryous, Liza L Cox, Natalie C Butterfield, Carol Wicking, Marnie E Blewitt, Sarah J Wilkins and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Professor Emma Whitelaw, a pioneer of epigenetic inheritance.Frontiers in epigenetics and epigenomics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  8. iScience · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. An N-ethyl-N-Nitrosourea Mutagenesis Screen in Mice Reveals a Mutation inAnimals : an open access journal from MDPI · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Alyson AsheEpigenetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland 4006, Australia. alyson.ashe@qimr.edu.au
Daniel K Morgan
Nadia C Whitelaw
Timothy J Bruxner
Nicola K Vickaryous
Liza L Cox
Natalie C Butterfield
Carol Wicking
Marnie E Blewitt
Sarah J Wilkins
Gregory J Anderson
Timothy C Cox
Emma Whitelaw
QIMR Berghofer Medical Research Institute · AUUniversity of Queensland · AUUniversity of Washington · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome years ago we established an N-ethyl-N-nitrosourea screen for modifiers of transgene variegation in the mouse and a preliminary description of the first six mutant lines, named MommeD1-D6, has been published. We have reported the underlying genes in three cases: MommeD1 is a mutation in SMC hinge domain containing 1 (Smchd1), a novel modifier of epigenetic gene silencing; MommeD2 is a mutation in DNA methyltransferase 1 (Dnmt1); and MommeD4 is a mutation in Smarca 5 (Snf2h), a known chromatin remodeler. The identification of Dnmt1 and Smarca5 attest to the effectiveness of the screen design.

resultsWe have now extended the screen and have identified four new modifiers, MommeD7-D10. Here we show that all ten MommeDs link to unique sites in the genome, that homozygosity for the mutations is associated with severe developmental abnormalities and that heterozygosity results in phenotypic abnormalities and reduced reproductive fitness in some cases. In addition, we have now identified the underlying genes for MommeD5 and MommeD10. MommeD5 is a mutation in Hdac1, which encodes histone deacetylase 1, and MommeD10 is a mutation in Baz1b (also known as Williams syndrome transcription factor), which encodes a transcription factor containing a PHD-type zinc finger and a bromodomain. We show that reduction in the level of Baz1b in the mouse results in craniofacial features reminiscent of Williams syndrome.

conclusionsThese results demonstrate the importance of dosage-dependent epigenetic reprogramming in the development of the embryo and the power of the screen to provide mouse models to study this process.

Indexed as

Embryonic DevelopmentEpigenesis, GeneticAnimalsBromodomain Containing ProteinsFemaleGenes, LethalGenomeHeterozygoteHistone Deacetylase 1Histone DeacetylasesMaleMiceMice, Inbred C57BLMice, Inbred StrainsMice, TransgenicTranscription FactorsBaz1b protein, mouseBromodomain Containing ProteinsHdac1 protein, mouseHistone Deacetylase 1Histone DeacetylasesTranscription Factors

Identifiers

PMID19099580
PMCPMC2646286
OpenAlexW2142568242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.